Interleukin-17 (IL-17) is a pro-inflammatory cytokine produced by activated T cells. It plays a crucial role in the immune response by regulating the activities of NF-kappaB and mitogen-activated protein kinases . The IL-17 family includes six cytokines (IL-17A to IL-17F), each with distinct roles in immune regulation .
IL-17RB, also known as IL-17 receptor B, is one of the receptors in the IL-17 family. It specifically binds to IL-17B and IL-17E (also known as IL-25) . IL-17RB is involved in various biological processes, including inflammation and immune response. It has been shown to stimulate the production of cytokines such as IL-6 and cyclooxygenase-2 (COX-2), as well as enhance the production of nitric oxide (NO) .
Recombinant IL-17RB (Mouse) is a bioengineered version of the IL-17RB protein derived from mouse cells. It is used in research to study the functions and signaling pathways of IL-17RB. This recombinant protein is produced using various expression systems, including E. coli and insect cells, to ensure its bioactivity and stability .
IL-17RB has been implicated in several diseases, including cancer and autoimmune disorders. In mouse models, IL-17B signaling through IL-17RB promotes cancer cell survival, proliferation, and migration, and induces resistance to conventional chemotherapeutic agents . This makes IL-17RB a potential therapeutic target for developing treatments for these diseases.